Linezolid for treatment of catheter-related cerebrospinal fluid infections in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 5, 2008, Pages

  Langgartner, Michaela ^a   Mutenthaler, A ^a   Haiden, N ^a   Pollak, A ^a   Berger, A ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ANASTOMOSIS; ANTIBIOTIC THERAPY; CEREBROSPINAL FLUID; DRUG EFFECT; DRUG SAFETY; HUMAN; HYDROCEPHALUS; LETTER; NEWBORN INFECTION; PREMATURITY; PRIORITY JOURNAL;

ACETAMIDES; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEREBROSPINAL FLUID; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; OXAZOLIDINONES; VENTRICULOSTOMY;

EID: 51449086426     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2008.140038     Document Type: Letter

References (4)

1. Pfausler B, Spiss H, Seer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040-4.
2. Jungbluth GL, Welshman IR, Hopkins NK. Linezolid pharmacokinetics in pediatric patients: an overview. Pediatr Infect Dis J 2003;22(Suppl 9):S153-7.
3. Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin in the treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 2003;22:677-85.
4. Deville JG, Alder S, Azimi PH, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates. Pediatr Infect Dis J 2003;22(Suppl 9):S158-63.